Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

Rebekka Weber(University Hospital Heidelberg), Viktor Umansky(University of Mannheim)
Frontiers in Immunology
June 11, 2018
Cited by 548


Related Papers